At a data monitoring committee’s recommendation, Merck and Intercell have stopped clinical trials testing the efficacy of a potential staph infection vaccine, according to a BusinessWeek news report.

Intercell AG was forced to plan deep cuts to its R&D operations after a key vaccine patch program, originally obtained from its 2008 buyout of Iomai, failed in a late-stage study. As part of the ...

VIENNA, March 2 (Reuters) - Austrian biotech firm Intercell suffered a 71-percent drop in its fourth-quarter pretax profit as revenue declined and research spending rose, the company said on Monday.

VIENNA, Aug 13 (Reuters) - Austrian vaccine maker Intercell said on Monday it expected to post its first full-year profit this year, despite a bigger second-quarter loss, as it expects revenues to ...